EP2956477
OPTIMIZED FACTOR VIII GENE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.2.2014EP published:
18.11.2020EP application number:
14751254.5
EPO information:
European Patent Register
Max expiry date:
13.2.2034
Title:
OPTIMIZED FACTOR VIII GENE
Timeline
Today
14.2.2014EP application
18.11.2020EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham, MA 02451, US
Inventor
Name:
TAN, SiyuanAddress:
Lexington, Massachusetts 02421, US
Name:
PETERS, Robert, T.Address:
Needham, Massachusetts 02492, US
Priority
Number:
201361765626 PDate:
15.2.2013Country:
US
Classification
Categories:
C07K 14/755